Smartleaf Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Hold
1,433
﹤0.01% 980
2026
Q1
$140K Buy
1,433
+16
+1% +$1.64K 0.01% 952
2025
Q4
$153K Sell
1,417
-190
-12% -$22K 0.01% 949
2025
Q3
$202K Buy
1,607
+223
+16% +$26.5K 0.01% 730
2025
Q2
$169K Sell
1,384
-131
-9% -$15K 0.01% 631
2025
Q1
$153K Buy
1,515
+997
+192% +$97.3K 0.01% 661
2024
Q4
$47.9K Buy
518
+88
+20% +$8.64K ﹤0.01% 1201
2024
Q3
$41.3K Buy
430
+108
+34% +$9.71K 0.01% 985
2024
Q2
$27.6K Buy
322
+97
+43% +$8.14K ﹤0.01% 914
2024
Q1
$17.5K Buy
225
+70
+45% +$5.13K ﹤0.01% 884
2023
Q4
$0 Buy
+155
New +$10K ﹤0.01% 1159

Other funds holding EHC

Smartleaf Asset Management's EHC Position: Q2 2026 in Review

Smartleaf Asset Management held its Encompass Health (EHC) position steady in Q2 2026 at 1,433 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Smartleaf Asset Management first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $202K in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Smartleaf Asset Management held 1,433 shares of Encompass Health worth $145K as of Q2 2026.
  • Smartleaf Asset Management left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #980 holding.
  • Smartleaf Asset Management first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Encompass Health position peaked at $202K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.